Gerli et al. (23) indicated that SS patients had significantly less nitrate-mediated vasodilation, and those in the subgroup with leukopenia and anti-SSB antibodies had higher levels of VCAM-1 and ICAM-1. This evidence concerns the gene SSB and synovial sarcoma.